Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Non-COVID Part B Lab Spend Declined by 15.9% in 2020

OIG says 2020 Medicare Part B CLFS spending for non-COVID tests was $6.5 billion, lowest since 2016

MEDICARE PART B CLINICAL LABORATORY FEE SCHEDULE CUTS mandated by PAMA continue to bite deeply. A new government report shows that during fiscal 2020, the Medicare program spent 15.9% less for lab tests, when COVID-19 test payments are excluded.  The federal Department of Health and Human Services Office of Inspector General (OIG) recently released a …

Non-COVID Part B Lab Spend Declined by 15.9% in 2020 Read More »

To access this post, you must purchase The Dark Report.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.